Clearbridge Health Ltd. · SGX:1H3
Clearbridge Health — Investor Presentation (March 2022)
23 slides from Clearbridge Health's investor presentation, Mar 9, 2022
Slide 1: Redefining Healthcare in Asia with Our Integrated Solutions and Expanding Presence
REDEFINING HEALTHCARE IN ASIA WITH OUR INTEGRATED SOLUTIONS AND EXPANDING PRESENCE
Slide 2: Important Notice
IMPORTANT NOTICE Clearbridge Health Limited (the “Company”) is a company listed on the Catalist Board of the Singapore Exchange Securities Trading Limited (the “SGX-ST”). This presentation has been prepared by the Company and has been reviewed by the Company’s sponsor, United Overseas Bank Limited (
Slide 3: Introduction
INTRODUCTION Clearbridge Health CBMG: Medical Clinics/ Centres Healthcare Systems Medtech Investments A regional healthcare • A regional healthcare services and product distribution • Operates over 23 hemodialysis • Biolidics Limited (Biolidics), an associate group centres and 24 clinical laboratori
Slide 4: Group Structure
GROUP STRUCTURE Clearbridge Health (CBH) SGX: 1H3 Healthcare CBMG: Medical Clinics/Centres Systems Medtech Investments 80.2% 100% 100% 100% Clearbridge Medical Group (CBMG) Clearbridge Assays SAM Laboratory Clearbridge BSA Effective Effective 100% 51% 85% 100% 55% 79.8% 22.7% 1.1% Clearbridge Clearb
Slide 5: Key Milestones
KEY MILESTONES Raised S$11.5m of Convertible BUILDING A REGIONAL HEALTHCARE GROUP IN ASIA Preference Shares at Subsidiary Level Successfully Obtained Approval by the FDA of Placement of S$11.3m Clearbridge Medical Group (CBMG) the Philippines for of Shares raised S$11.5m by way of a convertible COVI
Slide 6: Value Creation Process
VALUE CREATION PROCESS DRIVEN BY AN EBITDA-FOCUSED EXPANSION STRATEGY Unlocking Value Synergies Realisation Leverage Growth Value Realisation • Capitalising valuation • Maximising revenue growth by multiple differential between • Reducing cost of capital by • Building a detachable achieving economie
Slide 7: CBMG
CBMG A REGIONAL MARKET ACCESS NETWORK OF HEALTHCARE PRODUCT AND SERVICES HONG KONG PHILIPPINES ▪ Clearbridge Medical Group SINGAPORE (Hong Kong), a medical clinic in ▪ Clearbridge Medical Philippines, a 4- Causeway Bay caters to medical storey multi-specialty medical centre ▪ Medic Surgical and Lase
Slide 8: Healthcare Systems
HEALTHCARE SYSTEMS OPERATES LABORATORIES AND HEMODIALYSIS CENTRES UNDER PUBLIC-PARTNERSHIP MODEL IN INDONESIA IGM Labs • Jointly operate 24 laboratories and patient care facilities with public and private hospitals RSUH Adam Malik RSU Dr. Zainoel Abidin Sanglah General Hospital • 5 of the partnering
Slide 9: Financial Highlights
FINANCIAL HIGHLIGHTS Revenue (S$’000) 40,000 • Overall revenue declined 5.9% from S$36.3m in FY20 to S$34.1m in CAGR: 77.2% 36,258 34,123 FY21 due to non-recurring revenue of S$10.0m in 2020 in relation to 35,000 Between FY18-FY21 sales of COVID-19 antibody test kits and personal protection 30,000 1
Slide 10: Recent Developments: Expansion into New Business – Investment
RECENT DEVELOPMENTS EXPANSION INTO NEW BUSINESS – INVESTMENT • The Group had on 5 November 2021, obtained shareholders’ approval to expand into a new business – Investment • The investment business is involved in the business of investing into various entities in the global healthcare sector which a
Slide 11: Recent Developments: Home-Use COVID-19 ART Test Kits
RECENT DEVELOPMENTS IMPORTATION AND DISTRIBUTION OF HOME-USE COVID-19 ART TEST KITS APPROVED BY THE PHILIPPINES FDA • The Group has successfully registered the Labnovation Technologies Inc. (“Labnovation”)’s home-use COVID_19 antigen rapid test kits (“COVID-19 ART Test Kits”) with the Food and Drug
Slide 12: Merits of Clearbridge Health
MERITS OF CLEARBRIDGE HEALTH Direct proxy to the defensive Global trend of innovative and Differentiated business strategy Ecosystem of complementary and high-growth healthcare advanced healthcare solutions by building the first broad business components with industry in Asia underpins the industry’
Slide 13: Appendix
APPENDIX
Slide 14: Management Team
MANAGEMENT TEAM JEREMY YEE JONATHAN LIAU SIMON HOO FEXLICIA LEE Executive Director Chief Operating Chief Business Financial Controller and CEO Officer Officer • FormerCEO-Cordlife • FormerVPInvestments- • Former CEO - Life • Former FC - LifeCorporation GroupLimited(SGX-listed) EDBI Corporation Servi
Slide 15: CBMG: Singapore
CBMG: SINGAPORE AESTHETICS, MEDICAL & DENTAL CLINICS Dr Loo & therapists Aesthetics & medical Treatment room Clinics located at clinic at outskirts of heartlands CBD 15
Slide 16: CBMG: Singapore – Sinopharm COVID-19 Vaccine
CBMG: SINGAPORE ONE OF THE FIRST HEALTHCARE INSTITUTIONS TO ADMINISTER THE SINOPHARM COVID-19 VACCINE IN SINGAPORE Introduce Sinopharm COVID-19 vaccine in our Singapore clinic to accelerate Singapore’s vaccination rates. 16
Slide 17: CBMG: Philippines
CBMG: PHILIPPINES MULTI-SPECIALTY MEDICAL CENTRE AND CLINICS 4-storey medical Hemodialysis centre Covid-19 testing In-house pharmacy centre services 17
Slide 18: CBMG: Philippines
CBMG: PHILIPPINES MULTI-SPECIALTY MEDICAL CENTRE AND CLINICS Cone Beam CT Scan Adult/ Ortho Dentistry Marketing with Social Treatment room Pediatric Influencers 18
Slide 19: CBMG: Hong Kong
CBMG: HONG KONG CLEARBRIDGE MEDICAL HONG KONG Medical clinic located at Causeway Bay, Healthcare seminar conducted at clinic Hong Kong 19
Slide 20: Healthcare Systems in Indonesia: IGM Labs
HEALTHCARE SYSTEMS IN INDONESIA PT INDO GENESIS MEDIKA (IGM LABS) RSUP. Dr. Mohammad RS Cipto Mangunkusumo RS Umum Pusat Sanglah RS Umum Pusat H. Adam RSUD Dr. Zainoel RSUD Kabupaten Badung Hoesin Palembang Denpasar Bali Malik Medan Abidin Banda Aceh RS Jogja International Rumah Sakit Universitas RS
Slide 21: Healthcare Systems in Indonesia: IGM Labs
HEALTHCARE SYSTEMS IN INDONESIA PT INDO GENESIS MEDIKA (IGM LABS) Cash flows are highly recurring as services are essential in nature Services are reimbursed by Indonesia health coverage program (BPJS) Joint operation contracts are typically 5-7 years with revenue sharing ratio of 55% to 70% to IGM
Slide 22: Healthcare Systems in Indonesia: TMJ
HEALTHCARE SYSTEMS IN INDONESIA PT TIRTA MEDIKA JAYA (TMJ) Cash flows are highly recurring as patients undergo approximately 3 hemodialysis treatments/ week Services are reimbursed by Indonesia health coverage program (BPJS) Joint operation contracts are typically 7-10 years with revenue sharing rat
Slide 23: End of Presentation
END OF PRESENTATION Tel: 6251 0136 Add: 37 Jalan Pemimpin #08-05 Mapex Singapore 577177
Clearbridge Health — Investor Presentation (March 2022) on 6ix